$XGN
EXAGEN INC. Stock $xgn

$xgn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000127473724000048 Filed on May 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$15.06M	$14.42M
YoY Change	6.56%	28.36%
Cost Of Revenue	$6.008M	$5.817M
YoY Change	2.95%	-1.84%
Gross Profit	$9.056M	$8.598M
YoY Change	9.1%	62.1%
Gross Profit Margin	60.12%	59.65%
Selling, General & Admin	$10.46M	$10.54M
YoY Change	-12.46%	-11.29%
% of Gross Profit	115.55%	122.61%
Research & Development	$1.179M	$1.059M
YoY Change	-6.65%	-5.95%
% of Gross Profit	13.02%	12.32%
Depreciation & Amortization	$400.0K	$500.0K
YoY Change	-20.0%	-16.67%
% of Gross Profit	4.42%	5.82%
Operating Expenses	$11.64M	$11.60M
YoY Change	-11.9%	-10.83%
Operating Profit	-$2.587M	-$3.003M
YoY Change	-47.37%	-61.03%
Interest Expense	-$560.0K	$549.0K
YoY Change	-197.56%	-13.95%
% of Operating Profit
Other Income/Expense, Net	$181.0K	$192.0K
YoY Change	-61.97%	-70.73%
Pretax Income	-$2.966M	-$3.360M
YoY Change	-40.83%	-56.3%
Income Tax
% Of Pretax Income
Net Earnings	-$2.966M	-$3.360M
YoY Change	-40.83%	-56.3%
Net Earnings / Revenue	-19.69%	-23.31%
Basic Earnings Per Share	-$0.16	-$0.19
Diluted Earnings Per Share	-$0.16	-$0.19
COMMON SHARES
Basic Shares Outstanding	17.37M shares	17.24M shares
Diluted Shares Outstanding	18.18M shares	17.94M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.48M	$27.27M
YoY Change	-22.2%	-47.75%
Cash & Equivalents	$24.48M	$27.27M
Short-Term Investments
Other Short-Term Assets	$2.874M	$2.100M
YoY Change	73.87%	20.97%
Inventory
Prepaid Expenses
Receivables	$11.70M	$10.90M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$40.79M	$42.40M
YoY Change	-20.43%	-35.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.000M	$7.847M
YoY Change	-34.89%	-39.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$513.0K	$561.0K
YoY Change	-17.26%	-6.97%
Total Long-Term Assets	$8.513M	$8.408M
YoY Change	-34.04%	-37.8%
TOTAL ASSETS
Total Short-Term Assets	$40.79M	$42.40M
Total Long-Term Assets	$8.513M	$8.408M
Total Assets	$49.31M	$50.81M
YoY Change	-23.17%	-35.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.330M	$1.470M
YoY Change	78.0%	-21.73%
Accrued Expenses	$5.658M	$6.040M
YoY Change	-4.64%	-0.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$423.0K	$268.0K
YoY Change	64.59%	5.51%
Total Short-Term Liabilities	$9.446M	$8.783M
YoY Change	9.8%	-5.23%
LONG-TERM LIABILITIES
Long-Term Debt	$19.83M	$19.27M
YoY Change	3.53%	-33.77%
Other Long-Term Liabilities	$219.0K	$268.0K
YoY Change	-63.32%	-63.09%
Total Long-Term Liabilities	$20.05M	$19.54M
YoY Change	1.51%	-34.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.446M	$8.783M
Total Long-Term Liabilities	$20.05M	$19.54M
Total Liabilities	$31.72M	$30.82M
YoY Change	-1.72%	-28.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$285.5M	-$282.6M
YoY Change	6.45%	7.37%
Common Stock	$17.00K	$17.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.59M	$19.99M
YoY Change
Total Liabilities & Shareholders Equity	$49.31M	$50.81M
YoY Change	-23.17%	-35.88%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$2.966M	-$3.360M
YoY Change	-40.83%	-56.3%
Depreciation, Depletion And Amortization	$400.0K	$500.0K
YoY Change	-20.0%	-16.67%
Cash From Operating Activities	-$2.426M	-$9.040M
YoY Change	-76.11%	-7.27%
INVESTING ACTIVITIES
Capital Expenditures	$136.0K	$86.00K
YoY Change	-58.02%	-78.28%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$136.0K	-$86.00K
YoY Change	-57.76%	-78.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-226.0K	-$100.0K
YoY Change	-97.79%	61.29%
NET CHANGE
Cash From Operating Activities	-2.426M	-$9.040M
Cash From Investing Activities	-136.0K	-$86.00K
Cash From Financing Activities	-226.0K	-$100.0K
Net Change In Cash	-2.788M	-$9.226M
YoY Change	-86.54%	-9.61%
FREE CASH FLOW
Cash From Operating Activities	-$2.426M	-$9.040M
Capital Expenditures	$136.0K	$86.00K
Free Cash Flow	-$2.562M	-$9.126M
YoY Change	-75.55%	-10.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7688000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5817000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5926000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10542000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11884000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1059000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1126000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	17418000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	18936000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3003000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7706000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	549000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	638000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	192000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	656000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3360000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7688000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17944438	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17944438	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17526763	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17526763	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	22694000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	104000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	553000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3360000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	19991000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	42460000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	27000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	152000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	986000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7688000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	35937000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3360000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	458000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	553000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	37000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	42000	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	68000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	137000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-36000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-55000	usd
CY2024Q1	exdx	Non Cash Lease Expense NonCashLeaseExpense	214000	usd
CY2023Q1	exdx	Non Cash Lease Expense NonCashLeaseExpense	234000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	553000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	986000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4350000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3226000	usd
CY2024Q1	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-565000	usd
CY2023Q1	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	86000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-54000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	79000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-235000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-250000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1649000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1320000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1431000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	893000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9040000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9749000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	396000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-86000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-396000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27000	usd
CY2024Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	104000	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	152000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	139000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	189000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	65000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	52000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-62000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9226000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10207000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36693000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62591000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27467000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52384000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	434000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	449000	usd
CY2024Q1	exdx	Equipment Purchased Under Notes Payable Obligations EquipmentPurchasedUnderNotesPayableObligations	0	usd
CY2023Q1	exdx	Equipment Purchased Under Notes Payable Obligations EquipmentPurchasedUnderNotesPayableObligations	250000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	199000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27300000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-282600000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risk and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents and accounts receivable. Substantially all the Company's cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its cash or cash equivalents.</span></div>
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14415000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11230000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27267000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36493000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27467000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36693000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2500000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	300000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	300000	usd
CY2024Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	34000	usd
CY2023Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	35000	usd
CY2024Q1	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	2077000	usd
CY2023Q4	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	1860000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3130071	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2937005	shares
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2100000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2871000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	21000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	31000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4232000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4797000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	10444000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	10970000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5669000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5769000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4775000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5201000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	600000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3711000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4738000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	140000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	139000	usd
CY2024Q1	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	634000	usd
CY2023Q4	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	720000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	219000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	463000	usd
CY2024Q1	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	0	usd
CY2023Q4	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	118000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	438000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	490000	usd
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	311000	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	302000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	587000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	561000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6040000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7531000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1466000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1974000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	21243000	usd
CY2024Q1	exdx	Long Term Debt Including Undiscounted Interest LongTermDebtIncludingUndiscountedInterest	24683000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	103000	usd
CY2024Q1	exdx	Long Term Debt Undiscounted Interest Amount LongTermDebtUndiscountedInterestAmount	5043000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	19537000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	268000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19269000	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	8000000.0	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	9200000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1214059	shares
CY2024Q1	exdx	Stock Issued During Period Shares Warrants Exercised Net StockIssuedDuringPeriodSharesWarrantsExercisedNet	0	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	200000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	553000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	986000	usd

Files In Submission

Name	View Source	Status
exdx-20240331_def.xml	Edgar Link	unprocessable
0001274737-24-000048-index-headers.html	Edgar Link	pending
0001274737-24-000048-index.html	Edgar Link	pending
0001274737-24-000048.txt	Edgar Link	pending
0001274737-24-000048-xbrl.zip	Edgar Link	pending
exdx-20240331.htm	Edgar Link	pending
exdx-20240331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
innovatusfourthamendmentto.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
exdx-20240331_cal.xml	Edgar Link	unprocessable
exdx-20240331_lab.xml	Edgar Link	unprocessable
exdx-20240331_pre.xml	Edgar Link	unprocessable
exdx-20240331_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xgn311-033124.htm	Edgar Link	pending
xgn312-033124.htm	Edgar Link	pending
xgn321-033124.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XGN
EXAGEN INC. Stock $xgn

2024 Q2 Form 10-Q Financial Statement

#000127473724000048 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN EXAGEN INC. Stock $xgn

2024 Q2 Form 10-Q Financial Statement

#000127473724000048 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN
EXAGEN INC. Stock $xgn